Swedbank Ab Royalty Pharma PLC Transaction History
Swedbank Ab
- $95.2 Billion
- Q3 2025
A detailed history of Swedbank Ab transactions in Royalty Pharma PLC stock. As of the latest transaction made, Swedbank Ab holds 12,200,270 shares of RPRX stock, worth $478 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
12,200,270
Previous 12,157,470
0.35%
Holding current value
$478 Million
Previous $438 Million
1.74%
% of portfolio
0.45%
Previous 0.51%
Shares
14 transactions
Others Institutions Holding RPRX
# of Institutions
536Shares Held
304MCall Options Held
1.34MPut Options Held
252K-
Morgan Stanley New York, NY44.2MShares$1.73 Billion0.1% of portfolio
-
Capital International Investors Los Angeles, CA27.2MShares$1.07 Billion0.16% of portfolio
-
Black Rock Inc. New York, NY23MShares$901 Million0.01% of portfolio
-
Baillie Gifford & CO17.4MShares$680 Million0.48% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA12MShares$469 Million0.71% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $17.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...